Navigation Links
Fate Therapeutics Named One of the 50 Most Innovative Companies in the World by MIT's Technology Review
Date:2/26/2010

Technology Review, Inc., an independent media company owned by MIT, is the authority on the future of technology, identifying emerging technologies and analyzing their impact for leaders. Technology Review's media properties include Technology Review magazine, the oldest technology magazine in the world (founded in 1899); the daily news website TechnologyReview.com; and events such as the annual EmTech@MIT Conference.

About Fate Therapeutics, Inc.

Fate Therapeutics is interrogating adult stem cell biology and applying induced pluripotent stem cell (iPSC) technology to develop Stem Cell Modulators (SCMs), small molecule or biologic compounds that guide cell fate for therapeutic purposes.  The Company's award-winning, proprietary iPSC technology platform incorporates the most advanced viral, small molecule and protein reprogramming methods and offers a highly efficient, minimally invasive system to recapitulate human physiology for commercial-scale drug discovery and therapeutic use.  The Company's approach has broad therapeutic potential in areas such as regenerative medicine, hematological diseases, metastatic cancer, traumatic injury and degenerative diseases.  Fate Therapeutics is currently conducting a Phase 1b clinical trial of FT1050, a small molecule SCM designed to increase hematopoietic stem cell number and function in dual umbilical cord blood transplant recipients with hematologic malignancies, such as leukemia and lymphoma.  Fate Therapeutics is
'/>"/>

SOURCE Fate Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Amsterdam Molecular Therapeutics Reports Full Year Results 2009
2. Ocera Therapeutics Completes Phase 2B Enrollment in the ASTUTE Trial
3. Cornerstone Therapeutics to Host Fourth Quarter and Full-Year 2009 Conference Call
4. 3SBio and Ascentage Pharma Form Strategic Alliance to Research, Develop and Commercialize Cancer Therapeutics
5. United Therapeutics Corporation to Announce Fourth Quarter and Annual 2009 Financial Results Before Market Open on Tuesday, February 16, 2010
6. Amicus Therapeutics Board of Directors Names Chief Executive Officer John F. Crowley Chairman of the Board
7. Silence Therapeutics to Present at 12th Annual BIO CEO & Investor Conference
8. Aegera Therapeutics Initiates a Randomized Phase 2 Study with AEG35156 for the Treatment of Hepatocellular Carcinoma
9. Oxygen Biotherapeutics, Inc. Outlines Plans for New Products During Investor Conference Presentation
10. The Honorable Tommy G. Thompson Joins the United Therapeutics Corporation Board of Directors
11. Cell Therapeutics Commits to PhRMAs Code on Interactions With Healthcare Professionals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 17, 2014 Beckman Coulter , ... and healthcare, has renewed its agreement with Personify ... of the agreement, Personify will continue to streamline the ... on recruitment analytics, including time-to-fill, time-to-source and a deep ... agreement with Personify was based on the success of ...
(Date:9/17/2014)... Cambridge, MA (PRWEB) September 17, 2014 ... and Safety (ACRES) , a multi-stakeholder non-profit collaborative ... and efficiency in clinical research, today announced Phase ... (SASI). , Amir H. Kalali, ... Quintiles and Arti Bajpai, President, Compliance and Quality ...
(Date:9/16/2014)... emerging field of molecular electronics could take our ... the construction of tiny circuits from molecular components. ... take on the roles currently played by comparatively-bulky ... researchers from five Japanese and Taiwanese universities has ... electronics: a molecule called picene. In a paper ...
(Date:9/16/2014)... 16, 2014  Donald Fresne, President and CEO of Egenix, ... Vagner , PhD to its Scientific Advisory Committee. ... Toulouse, France , performed research at Embl (European Molecular ... Inserm, the French institute of health and medical research. He ... the Curie Institute, Orsay, France , and ...
Breaking Biology Technology:Beckman Coulter Signs 3-year RPO Contract with Personify 2Beckman Coulter Signs 3-year RPO Contract with Personify 3Global Standards Initiative for Clinical Research Sites Advances 2Global Standards Initiative for Clinical Research Sites Advances 3Global Standards Initiative for Clinical Research Sites Advances 4The future face of molecular electronics 2New Appointment to the Scientific Advisory Committee at Egenix, Inc. 2
... Oncolytics Biotech Inc. (TSX:,ONC, NASDAQ: ONCY) ("Oncolytics") ... Patent 7,374,752 entitled "Reovirus for the Treatment ... compositions,which comprise various recombinant reoviruses., "This ... protection for,reovirus compositions in the United States," ...
... of Two-Phase Examination of U.S. Asthma Control, RESEARCH ... half of adult Americans with asthma and more than ... nationally representative survey do,not have their disease well controlled, ... at the International Conference of the American,Thoracic Society meeting ...
... 20 CellCyte Genetics,Corporation (CellCyte) (OTC Bulletin ... H. Traverse, M.D., FACC, FAHA, to its ... is an interventional,cardiologist with the Minneapolis Heart ... in cardiovascular stem cell clinical,trial research., ...
Cached Biology Technology:Oncolytics Biotech Inc. Announces Issuance of 27th U.S. Patent 2Asthma Uncontrolled in More Than 40 Percent of Adults With the Disease, New Landmark Survey Shows 2Asthma Uncontrolled in More Than 40 Percent of Adults With the Disease, New Landmark Survey Shows 3CellCyte Genetics Corp. Appoints Jay H. Traverse to Scientific Advisory Board as Clinical Consultant 2CellCyte Genetics Corp. Appoints Jay H. Traverse to Scientific Advisory Board as Clinical Consultant 3
(Date:9/16/2014)... Philadelphia, PA, September 16, 2014 Schizophrenia is associated ... A growing body of research suggests that the relationship ... effort by patients to use nicotine to self-medicate symptoms ... new study, published in the current issue of ... authors found that the level of nicotine receptors in ...
(Date:9/16/2014)... are responsible for practically all vital functions in ... forward signals, transport particular substances and control immune ... proteins do not function independently of each other, ... examine the protein networks, you find many similarities ... from TUM,s Chair of Plant Systems Biology. "Some ...
(Date:9/15/2014)... microbes influence processes from digestion to disease resistance. Despite ... terrestrial ecosystems on the planet, more is known about ... Smithsonian scientists and colleagues working on Panama,s Barro Colorado ... tree were home to more than 400 different kinds ... contained more than 7,000 different kinds. , Bacteria in ...
Breaking Biology News(10 mins):Smoking and schizophrenia linked by alterations in brain nicotine signals 2Good networkers make prime targets 2Smithsonian scientists discover tropical tree microbiome in Panama 2
... flowers has been recreated by mathematicians at The University of ... the University of Cambridge to create a mathematical model of ... in flowering plants and the role it may play in ... as you alter the angle you view it from. It ...
... French and German . ... Scientists have been able to reconstruct, for the first ... tetrapods, the earliest four-legged animals. High-energy X-rays and a new ... of the 360 million year old fossils in exceptional detail ...
... quickly than the supply of honey bees, the dominant ... pollination represents a way of increasing crop yield without ... study recently published in the Proceedings of ... 2013) 1, shows that the pollination effectiveness of honey ...
Cached Biology News:How does your garden glow? 2Scientists reassemble the backbone of life with a particle accelerator 2Scientists reassemble the backbone of life with a particle accelerator 32 new studies show why biodiversity is important for pollination services in California almond 2
EDG-6 (1)...
...
...
... Comments: Ab-1 stains tumor cells of embryonal ... type of germ cell tumors like seminoma. Glandular ... are positive. Luminal and endocrine cells of stomach ... breast are also positive. Epitope: Carbohydrate ...
Biology Products: